Results 81 to 90 of about 6,701 (204)

Transposition of the great arteries and hypocalcemia in a patient with fetal hydantoin syndrome [PDF]

open access: yes, 2002
We report a patient with fetal hydantoin syndrome (FHS) with associated d-transposition of the great arteries (d-TGA) and persistent hypocalcemia.
Mrugeshkumar K Shah   +7 more
core   +1 more source

Synthesis, Structure and Cytotoxicity of Platinum(IV) Complexes of 3-Aminocyclohexanespiro-5-hydantoin and 3-Aminocycloheptanespiro-5-hydantoin [PDF]

open access: yes, 2009
Two new platinum(IV) complexes of 3-aminocyclohexanespiro-5-hydantoin (achsh) and 3-aminocycloheptanespiro-5-hydantoin (achpsh) were prepared and characterized.
Spassovska, Nadejda   +11 more
core   +1 more source

Comparative metabolism of hydantoin and beta-methyl hydantoin.

open access: yesExperimental Biology and Medicine, 1926
In previous experiments1 it was pointed out that when betamethyl hydantoin is given subcutaneously to dogs only fifteen per cent of the compound reappears unchanged in the urine. A similar amount is excreted as methyl hydantoic acid. But while all of the nitrogen of the compound was excreted, the remainder was unaccounted for in the nitrogen partition.
openaire   +1 more source

ADAM17 and its proteolytic targets in disease pathogenesis

open access: yesThe FEBS Journal, Volume 293, Issue 16, Page 4789-4804, August 2026.
ADAM17 as a multifunctional sheddase with contrasting roles across inflammatory, metabolic, cardiovascular, and neoplastic diseases. Through regulated activation by iRhom, iTAP/FRMD8, and tetraspanins, ADAM17 cleaves diverse membrane ligands and receptors, thereby promoting inflammation, fibrosis, obesity, insulin resistance, and tumor progression ...
Abdulbasit Amin, Marina Badenes
wiley   +1 more source

Probing 5‐Nitroimidazole‐Triazole Hybrids as Potential Anti‐Kinetoplastid Agents: Synthesis and In Vitro Efficacy

open access: yesChemMedChem, Volume 21, Issue 13, 14 July 2026.
A series of 5‐nitroimidazole‐1,2,3‐triazole hybrids was synthesised and evaluated for antitrypanosomatid activity to assess their potential as treatments against leishmaniasis and trypanosomiasis. No notable in vitro activity against Leishmania was detected.
Liandi Ferreira   +4 more
wiley   +1 more source

Three-Component, One-Pot Sequential Synthesis of Glyco-Hydantoin Conjugates

open access: yes, 2011
The development of new methods for linking sugars to heterocycles and peptides is an attractive area of research because glyco-conjugates play important roles in biology and medicine and are indispensable tools for probing several processes.
A. Volonterio   +6 more
core   +1 more source

Frontier Advances of Terpyridine–Zn(II) Complexes: From Molecular Design to Smart Functional Materials

open access: yesAdvanced Science, Volume 13, Issue 42, 28 July 2026.
Tpy–Zn complexes serve as versatile building blocks for the modular assembly of functional materials, including polymers, gels, MOFs, cages, and composites through programmed noncovalent interactions, empowering practical applications in visual molecular recognition, smart functional materials, and photocatalytic transformations. ABSTRACT As one of the
Lixin Duan   +4 more
wiley   +1 more source

3’-Methyl-4-thio-1H-tetrahydropyranspiro-5’-hydantoin platinum complex as a novel deoxyribonuclease I inhibitor [PDF]

open access: yesPharmacia
Deoxyribonuclease I (DNase I) is one of the main nucleases involved in deoxyribonucleic acid (DNA) degradation during apoptosis. It catalyzes the hydrolytic cleavage of DNA, producing 5‘-oligonucleotides.
Ana Marković   +5 more
doaj   +3 more sources

Infrared studies of hydantoin and its derivatives

open access: yes, 1967
Infrared absorption spectral characteristics of hydantoin and its akyl, aryl and aralkyl derivatives are reported. The major peaks of comparative significance are discussed in detail.
P N NATARAJAN, T H ELLIOTT
core   +1 more source

Hydantoin derivative compounds, methods of use and methods of treatment

open access: yes, 2020
The present disclosure provides compositions including a hydantoin derivative compound, pharmaceutical compositions including a hydantoin derivative compound, methods of treatment of a condition (e.g., bacterial infection) or disease, methods of ...
Nimmagadda, Alekhya   +3 more
core  

Home - About - Disclaimer - Privacy